2026 Global: Continuous Syringes Market -Competitive Review (2032) report
Description
The 2026 Global: Continuous Syringes Market-Competitive Review (2032) report features the global market size and projected growth/decline data for the period 2021 and 2032. The report primarily provides an examination of the business strategies for the ten largest global companies in the market and how their strategies differ.
BD, Becton Dickinson and Company, remains a dominant force in the continuous syringe segment with a broad line of sterile syringes, specialty injectables, and related delivery systems that span clinical, pharmaceutical, and laboratory applications (Franklin Lakes, United States). Terumo Corporation, headquartered in Tokyo, Japan, concentrates on precision sterile syringes and injection devices designed for reliability in high demand environments. B. Braun Melsungen AG, based in Melsungen, Germany, integrates syringe fabrication with comprehensive infusion management systems to support hospital and outpatient care worldwide. Nipro Corporation, headquartered in Osaka, Japan, expands the market through high quality plastic and glass syringe products complemented by a dense manufacturing and distribution network. Collectively these four firms anchor the upper tier of the continuous syringe landscape, combining scale, regulatory familiarity, and global reach that shape pricing, supply resilience, and innovation trajectories across multiple geographies. These dynamics influence procurement strategies and research collaborations across institutions and networks.
West Pharmaceutical Services, headquartered in Exton, United States, is a leading provider of drug delivery systems including prefillable syringes, safety features, and associated components that enable scalable manufacturing and reliable patient administration. Gerresheimer AG, based in Düsseldorf, Germany, brings specialized glass and plastic syringe solutions that emphasize precision molding, sterile handling, and robust supply chains across regulated markets. Stevanato Group S.p.A., with corporate presence in Piombino Dese, Italy, focuses on glass syringe solutions for biologics and highly regulated therapies, integrating container systems with additive manufacturing and serialization to support traceability. Schott AG, headquartered in Mainz, Germany, contributes glass syringe manufacturing and related containment solutions that uphold high purity standards and compatibility with sensitive formulations. Together these four companies complement the core syringe manufacturing landscape by expanding material options, production technologies, and regional supply resiliency, while also driving standardization and compliance across evolving regulatory frameworks. These dynamics shape investment priorities globally.
AptarGroup, headquartered in Crystal Lake, Illinois, United States, provides drug delivery and containment systems including compatible syringes, plungers, and closures that support administration safety and patient comfort across hospital settings. Weigao Group Medical Polymer Co., Ltd., based in Weihai, China, offers syringe and needle assemblies, packaging components, and related medical devices strengthening regional supply chains and price competitiveness in Asia. The combined activities of these ten companies illustrate a global ecosystem that balances traditional glass and plastic syringe manufacturing with polymer integrations, safety engineering, serialization, and compliance with evolving regulatory requirements. Market observers note continued consolidation in supplier networks and a shift toward near shoring in key regions, driven by quality standards, import/export policies, and the need for rapid response to public health campaigns. In this context, continued investment in process automation and materials science appears essential for resilience and rising demand across healthcare systems and global networks in markets.
BD, Becton Dickinson and Company, remains a dominant force in the continuous syringe segment with a broad line of sterile syringes, specialty injectables, and related delivery systems that span clinical, pharmaceutical, and laboratory applications (Franklin Lakes, United States). Terumo Corporation, headquartered in Tokyo, Japan, concentrates on precision sterile syringes and injection devices designed for reliability in high demand environments. B. Braun Melsungen AG, based in Melsungen, Germany, integrates syringe fabrication with comprehensive infusion management systems to support hospital and outpatient care worldwide. Nipro Corporation, headquartered in Osaka, Japan, expands the market through high quality plastic and glass syringe products complemented by a dense manufacturing and distribution network. Collectively these four firms anchor the upper tier of the continuous syringe landscape, combining scale, regulatory familiarity, and global reach that shape pricing, supply resilience, and innovation trajectories across multiple geographies. These dynamics influence procurement strategies and research collaborations across institutions and networks.
West Pharmaceutical Services, headquartered in Exton, United States, is a leading provider of drug delivery systems including prefillable syringes, safety features, and associated components that enable scalable manufacturing and reliable patient administration. Gerresheimer AG, based in Düsseldorf, Germany, brings specialized glass and plastic syringe solutions that emphasize precision molding, sterile handling, and robust supply chains across regulated markets. Stevanato Group S.p.A., with corporate presence in Piombino Dese, Italy, focuses on glass syringe solutions for biologics and highly regulated therapies, integrating container systems with additive manufacturing and serialization to support traceability. Schott AG, headquartered in Mainz, Germany, contributes glass syringe manufacturing and related containment solutions that uphold high purity standards and compatibility with sensitive formulations. Together these four companies complement the core syringe manufacturing landscape by expanding material options, production technologies, and regional supply resiliency, while also driving standardization and compliance across evolving regulatory frameworks. These dynamics shape investment priorities globally.
AptarGroup, headquartered in Crystal Lake, Illinois, United States, provides drug delivery and containment systems including compatible syringes, plungers, and closures that support administration safety and patient comfort across hospital settings. Weigao Group Medical Polymer Co., Ltd., based in Weihai, China, offers syringe and needle assemblies, packaging components, and related medical devices strengthening regional supply chains and price competitiveness in Asia. The combined activities of these ten companies illustrate a global ecosystem that balances traditional glass and plastic syringe manufacturing with polymer integrations, safety engineering, serialization, and compliance with evolving regulatory requirements. Market observers note continued consolidation in supplier networks and a shift toward near shoring in key regions, driven by quality standards, import/export policies, and the need for rapid response to public health campaigns. In this context, continued investment in process automation and materials science appears essential for resilience and rising demand across healthcare systems and global networks in markets.
Table of Contents
32 Pages
- 1.0 Scope of Report and Methodology
- 2.0 Market SWOT Analysis and Players
- 2.1 Market Definition
- 2.2 Market Segments
- 2.3 Market Strengths
- 2.4 Market Weaknesses
- 2.5 Market Threats
- 2.6 Market Opportunities
- 2.7 Major Players
- 3.0 Competitive Analysis
- 3.1 Market Player 1
- 3.2 Market Player 2
- 3.3 Market Player 3
- 3.4 Market Player 4
- 3.5 Market Player 5
- 3.6 Market Player 6
- 3.7 Market Player 7
- 3.8 Market Player 8
- 3.9 Market Player 9
- 3.10 Market Player 10
- 4.0 Comparative Business Strategies
- 4.1 Comparative Business Strategies of Player 1 and 2
- 4.2 Comparative Business Strategies of Player 1 and 3
- 4.3 Comparative Business Strategies of Player 1 and 4
- 4.4 Comparative Business Strategies of Player 2 and 3
- 4.5 Comparative Business Strategies of Player 2 and 4
- 4.6 Comparative Business Strategies of Player 3 and 4
- 5.0 Appendix
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
